A biller at a multi-state O&P practice opens a remittance advice for a custom-fabricated ankle-foot orthosis, billed at just over $2,800, and finds it denied for insufficient medical necessity documentation. The device was already molded, fabricated, and delivered three weeks earlier. Now the practice is out the cost of materials and lab time, with a patient already wearing the brace and a claim that may never get paid.
That’s what makes orthotics and prosthetics claim denials different from a routine DME rejection: the device is usually already built and fitted before anyone finds out the paperwork didn’t hold up. Between CMS’s newest prior authorization expansion, aggressive documentation audits, and a wave of 2026 policy changes AOPA’s National Assembly is putting front and center this month, O&P billing teams have more reason than ever to get ahead of denials instead of fighting them after the fact. Here’s why O&P claims get denied, what’s changing on October 28, 2026, and how to prevent and appeal denials that land anyway.
Quick Answer
Orthotics and prosthetics claim denials are caused primarily by documentation gaps, not device eligibility. The three leading causes are a written order prior to delivery (WOPD) completed after fabrication instead of before, medical necessity documentation that doesn’t meet payer standards, and missing prior authorization for codes now on CMS’s expanding Required PA List.
Lump orthotics and prosthetics in with general durable medical equipment and you’ll misdiagnose the problem. A rented wheelchair is a rental. It goes back if the payer says no. A custom-fabricated prosthetic socket, molded and built around one patient’s residual limb, doesn’t have a return path. Once it’s built, it’s built, so the entire cost sits on the provider’s side of the ledger until the claim clears.
O&P billing runs on HCPCS Level II L-codes (roughly L0100 through L9900), and each one carries its own chain of required documentation: a physician’s written order, a functional or K-level assessment for prosthetics, evidence the device matches how it was actually fabricated (custom, custom-fitted, or off-the-shelf), and, for a growing list of codes, a face-to-face encounter completed before the device is built. Miss any link in that chain and the claim is exposed, regardless of whether the device itself was medically appropriate. That’s the core reason DMEPOS claim denial reasons for O&P skew so heavily toward documentation and timing rather than coding errors alone.
The scale of this problem is easier to see in CMS’s own audit data than in any vendor’s marketing page. Medicare’s Comprehensive Error Rate Testing (CERT) program puts the overall DMEPOS improper payment rate at 24.12% for the FY2025 reporting period (claims from July 2023 through June 2024), totaling roughly $2.3 billion in improper payments across the category.
Orthotics specifically run even higher than the DMEPOS average. CMS’s own fraud-monitoring data shows orthotic braces carried an improper payment rate between 35.2% and 54.4% in FY2024, and a 2023 CERT sample broke that down further by how the device was fabricated:
| Device Fabrication Type | In-House Billing |
|---|---|
|
Custom-fabricated
|
53.3%
|
|
Custom-fitted
|
48.3% |
|
Off-the-shelf
|
58.3% |
CMS attributes the majority of these errors to missing or insufficient documentation, medical necessity that wasn’t clearly established, or devices furnished by personnel who weren’t licensed or certified in the state where they practiced – not fraud in the criminal sense, just paperwork that couldn’t hold up to review. This problem is trending the wrong direction, not improving: CMS’s Fraud Hot Spot data put the overall DMEPOS improper payment rate at 21.4% for FY2024, a figure confirmed independently in a December 2025 Federal Register notice. By the FY2025 CERT reporting period, that rate had climbed to 24.12%, well above the 6.55% improper payment rate MedPAC’s June 2026 report to Congress cites for Medicare fee-for-service overall, meaning DMEPOS claims are running at roughly four times the program-wide error rate. These aren’t abstract compliance statistics. They translate directly into the orthotics and prosthetics claim denials sitting on your AR aging report right now, and they’re the reason CMS keeps expanding, not shrinking, its prior auth list.
Starting October 28, 2026, CMS is adding several O&P HCPCS codes to its Required Prior Authorization List and its Required Face-to-Face Encounter and Written Order Prior to Delivery (WOPD) List, meaning Medicare won’t pay these claims without pre-approval and a completed encounter on file before the device is built.
Here’s the same information indexed by code, for quick lookup:
| HCPCS Code | Device Type | Requirement Starting Oct 28, 2026 |
|---|---|---|
|
L0456
|
Spinal orthosis
|
Prior authorization (nationwide) + F2F/WOPD
|
|
L0457
|
Spinal orthosis |
Prior authorization (nationwide) + F2F/WOPD
|
|
L0486
|
Spinal orthosis
|
Prior authorization (nationwide) + F2F/WOPD
|
|
L1833
|
Knee orthosis
|
Prior authorization (nationwide) + F2F/WOPD
|
|
L1906 |
Ankle-foot orthosis
|
Face-to-face + WOPD only
|
|
L1933
|
Ankle-foot orthosis
|
Face-to-face + WOPD; added to Master List
|
|
L1952
|
Ankle-foot orthosis
|
Face-to-face + WOPD; added to Master List
|
|
L3761
|
Upper extremity orthosis
|
Prior authorization (phased) + F2F/WOPD
|
|
L3916
|
Upper extremity orthosis
|
Prior authorization (phased) + F2F/WOPD
|
Taken together, this brings the total O&P codes requiring prior authorization to 27, and the total requiring a face-to-face encounter and WOPD to 32, according to AOPA’s own coding and reimbursement team. It’s not a coincidence that this expansion lands the same week as AOPA’s National Assembly (September 9-12, 2026), where prior auth workflow changes are already a major floor conversation heading into the October deadline.
Six issues account for most O&P billing denials we see, and nearly all of them trace back to timing or documentation rather than the device itself being inappropriate. A missing or incomplete written order prior to delivery is the single most common cause on the newly expanded code list, since CMS treats a WOPD obtained after fabrication as no WOPD at all. Close behind is medical necessity documentation that doesn’t actually establish necessity in the payer’s terms: a prescription that says “AFO” without the functional assessment, K-level, or clinical rationale a reviewer needs to approve it.
Misclassifying how a device was fabricated is a quieter but costly cause. Billing a custom-fitted device under a custom-fabricated L-code (or the reverse) triggers a mismatch the payer can catch on review, and given the error rates above run high across all three fabrication categories, this isn’t a minor technicality to a DME MAC auditor. A missing or expired prior authorization is the fourth major cause, and it’s about to become more common as the October 2026 code list grows. Rounding it out: billing under a practitioner whose ABC or BOC certification has lapsed, and modifier errors that fail to separate the device’s L-code from the practitioner’s own CPT service code – a distinction CMS treats as two separate billable events, not one.
Every cause above is preventable at the front end, before a claim is ever submitted, which is exactly where prevention needs to happen given how little recourse you have once a custom device is built.
When a denial does land, Medicare’s appeals process runs through the same five levels as any other Part B claim: redetermination with the DME MAC, reconsideration through a Qualified Independent Contractor, an Administrative Law Judge hearing, Medicare Appeals Council review, and finally federal court – though the overwhelming majority of O&P appeals resolve at the first two levels if the documentation is actually complete.
What makes an O&P appeal work is usually the same thing that would have prevented the denial: a complete WOPD, a functional assessment that ties directly to the device billed, and a citation to the relevant DME MAC’s Local Coverage Determination showing the device meets that payer’s specific medical necessity criteria, not just Medicare’s general standard. Given how much more a custom-fabricated device costs than a routine claim correction, ranking a denial backlog by dollar value before working it top-down matters more here than in most billing categories. A $150 off-the-shelf brace denial and a $4,000 custom-fabricated socket denial don’t deserve the same amount of staff time, and treating them equally is how real, recoverable money quietly turns into a permanent write-off instead of a reworked claim.
That’s precisely the gap our write-off recovery process is built to close for O&P practices sitting on an aging denial backlog: working the claims that were already given up on, not just the ones that landed this week.
If your practice isn’t heavy in the four Phase 1 states or the specific codes changing October 28, it’s tempting to file this under “not yet.” That would be a mistake. The documentation standard CMS is enforcing on this batch of codes, WOPD before fabrication, functional necessity that actually holds up, verified practitioner certification, is the direction every O&P code is heading, not a one-time carve-out. Practices that build the workflow now, before their own codes get added to a future list, are the ones who won’t be scrambling through a denial spike when it happens.
This is exactly where our orthotics and prosthetics billing team comes in, built around eight years of O&P-specific billing depth, not general DME billing with L-codes bolted on. We track the Required Prior Authorization List and F2F/WOPD List by code so your team doesn’t have to catch every CMS update manually, and we prioritize denial backlogs by device cost and deadline risk instead of working them in the order they arrived. See how we handle O&P billing differently than a general RCM vendor would.
Go back to that ankle-foot orthosis sitting in denial from the top of this piece. The mistake wasn’t clinical and it wasn’t even really a coding error, it was a documentation gate that closed before anyone checked it was open. That’s the pattern behind most orthotics and prosthetics claim denials, and it’s about to get less forgiving, not more, as CMS adds codes to the prior authorization and WOPD lists on October 28, 2026.
Three things worth taking away: build the WOPD into your workflow before fabrication starts, not after; document medical necessity like a CERT auditor will read it, because one eventually will; and rank your appeal backlog by dollar value, since a $4,000 custom socket denial and a $150 brace denial are not the same fight.
Scintillate RCM Healthcare has spent eight years in O&P and DMEPOS billing specifically, not general medical billing applied to L-codes after the fact. Request a free O&P billing and denial audit before the October 28 changes take effect, and find out exactly which of your claims are exposed.
A missing or incomplete written order prior to delivery (WOPD) is the most common cause, followed closely by medical necessity documentation that doesn’t clearly establish why the specific device was required. CMS treats a WOPD obtained after the device is fabricated as equivalent to having none at all.
Effective October 28, 2026, four codes require prior authorization nationwide: three spinal orthoses (L0456, L0457, L0486) and one knee orthosis (L1833). Two upper extremity orthoses (L3761, L3916) begin a phased rollout the same day, starting in California, Florida, New York, and Michigan.
A prescription authorizes treatment generally. A WOPD is a specific, dated written order for the exact device being billed, completed and signed before the device is fabricated or delivered. For codes on CMS’s Required F2F/WOPD List, a prescription alone doesn’t satisfy the requirement.
Medicare O&P appeals follow the standard five-level process, starting with redetermination through the DME MAC. Most successful appeals hinge on submitting the complete WOPD, a functional or K-level assessment tied to the specific device, and a citation to the relevant DME MAC’s Local Coverage Determination.
Based on 2023 CERT sample data, off-the-shelf devices actually carried a higher error rate (58.3%) than custom-fabricated devices (53.3%), often due to documentation gaps rather than fabrication complexity. DMEPOS claim denial reasons for off-the-shelf devices tend to center on medical necessity and coding accuracy rather than WOPD timing.
Free RCM Health Check. Receive a custom benchmark report comparing your performance against industry standards in 2 days.
Scintillate Healthcare LLC, Georgetown, Texas.
Cash Accelerated Care Elevated
